We present a model that considers the coevolution of genomic imprinting at a growth factor locus and an antagonistic growth suppressor locus. With respect to the two loci considered independently, our model makes the familiar predictions that an imprinted growth factor locus will only be expressed from the paternally derived allele and an imprinted growth suppressor locus only from the maternally derived allele. In addition, our coevolutionary model allows us to make predictions regarding the sequence of evolutionary events necessary for generating such a system. We conclude that imprinting at the growth factor locus preceded the evolution of growth suppressor function at the second locus, which in turn preceded imprinting at that locus. We then discuss the consistency of these predictions with currently available comparative data on the insulin-like growth factor 2^insulin-like growth factor 2 receptor system of mammals.
INTRODUCTION
Genomic imprinting refers to the phenomenon whereby some genes are expressed di¡erently depending on whether they are inherited via an egg or a sperm. The kinship or parental con£ict theory of imprinting (Trivers & Burt 1999; Haig 2000) proposes that imprinting evolves when the quantitative level of gene expression in an individual has ¢tness consequences for other individuals to whom the ¢rst has di¡erent degrees of matrilineal and patrilineal relatedness. When a gene is paternally derived, natural selection on expression levels favours alleles that increase patrilineal inclusive ¢tness, whereas when the gene is maternally derived, natural selection favours alleles that increase matrilineal inclusive ¢tness (Haig 1997 (Haig , 2000 . In the remainder of this paper we will follow the convention of using the adjectives madumnal and padumnal for denoting maternally derived and paternally derived alleles in o¡spring in contrast to the adjectives maternal and paternal, which are used to denote alleles in mothers and fathers (see Haig 1996) .
Strong selection for di¡erential gene expression can occur when o¡spring have an active role in acquiring resources from their mothers. In standard life-history theory, an o¡spring's optimal level of maternal investment is that which maximizes its inclusive ¢tness. The location of this optimum is governed by a trade-o¡ between bene¢ts to the o¡spring's personal ¢tness from increased investment and costs to sibs who receive less as a result, where these costs are discounted by their average coe¤cient of relatedness to the o¡spring (Trivers 1974) . The kinship theory recognizes that the coe¤cient of patrilineal relatedness for these sibs will commonly be less than their coe¤cient of matrilineal relatedness due to the possibility of multiple paternity of a female's o¡spring. That is, a set of o¡spring who must compete for limited maternal resources are on average more closely related through their mother than through their father(s).
Padumnal alleles therefore place greater weight on the bene¢t to the self in calculations of this trade-o¡, whereas madumnal alleles place greater weight on the cost to sibs.
The kinship theory predicts that the padumnal genome will favour higher expression than the madumnal genome at loci where increased expression acquires more maternal investment for an individual at a cost to its sibs. If the locus is unimprinted, the two alleles are constrained to exhibit the same expression level, and the evolutionarily stable level will occur somewhere between the two allelic optima. However, if the expression levels of the two alleles are able to evolve independently, the only evolutionarily stable expression pattern is one in which the madumnal allele is silent and the padumnal allele produces its preferred amount of the gene product (Haig 1997) . Conversely, padumnal silence is predicted at imprinted loci where increased expression provides a bene¢t to sibs by reducing the individual's demands on its mother.
The paradigmatic examples of oppositely imprinted genes are the insulin-like growth factor 2 (Igf 2) and insulinlike growth factor 2 receptor (Igf 2r) loci of mice (Haig & Graham 1991) . In mice, Igf 2 is only expressed from the padumnal allele (DeChiara et al. 1991) , whereas Igf 2r is only expressed from the madumnal allele (Barlow et al. 1991) . Inactivation of the padumnal allele of Igf 2 results in mice that are 60% of normal birth weight, whereas inactivation of the madumnal allele of Igf 2r results in mice that are 140% of normal birth weight (Ludwig et al. 1996) . The principal growth-related e¡ect of Igf 2r expression is the removal and degradation of the Igf 2 gene product (for a review, see O'Dell & Day 1998) .
Below, we present a model of the evolution of genomic imprinting in a system of two loci with opposing e¡ects on fetal growth. Our aim is to delineate plausible evolutionary scenarios for the coevolution of imprinting at antagonistic loci. In the context of the Igf 2^Igf 2r system, these scenarios can then be tested against comparative data (as it becomes available) from species in which one or both loci are unimprinted.
ASSUMPTIONS OF THE MODEL: STABILITY
Our model considers two loci, the ¢rst of which encodes a growth factor and the second a growth suppressor that acts by eliminating the product of the ¢rst locus. X (an individual's total production of growth factor) is the sum of x m (production by the madumnal allele at the ¢rst locus) and x p (production by the padumnal allele at that locus). Similarly, Y (the total production of the growth suppressor) is the sum of y m (madumnal production) and y p (padumnal production).
and
The pattern of expression at the two loci in a given individual can be summarized by a four-element vector that is denoted by square brackets, i.e. [x m , x p , y m , y p ]. This expression pattern is a property of an individual and should be distinguished from the expression strategies of alleles at the two loci. These will be represented by twoelement vectors that are denoted by curly brackets, i.e. {x m , x p } and { y m , y p }. Whereas x m and x p represent the (possibly di¡erent) expression levels of a single allele when it is maternally and paternally derived in a strategy vector, in a pattern vector x m and x p represent the expression levels of an individual's madumnal and padumnal gene copies, which may or may not represent di¡erent copies of the same allele.
An evolutionarily stable strategy (ESS) at the growth factor locus is de¢ned as a strategy {xª m , xª p } such that a population in which {xª m , xª p } is adopted by most alleles is resistant to invasion by any rare alternative strategy {x m , x p }6 {xª m , xª p }. Similarly, an ESS at the growth suppressor locus is de¢ned as a strategy { yª m , yª p } such that a population in which { yª m , yª p } is adopted by most alleles is resistant to invasion by any rare alternative strategy { y m , y p }6 { yª m , yª p }. An allele's strategy is only evolutionarily stable with respect to a speci¢c set of alternatives. In this paper, we will consider two di¡erent types of strategy set. If a locus is`imprinted', the set of possible strategies at the locus includes all pairs of non-negative madumnal and padumnal expression levels. If a locus is`unimprinted', we only consider the subset of strategies that satis¢es the additional constraint that the madumnal and padumnal expression levels are equal (i.e. x mˆxpˆxmp and/or y mˆypˆymp ). Thus, an ESS at an unimprinted locus may cease to be evolutionarily stable if the strategy set is expanded to include imprinted alleles.
The inclusive ¢tness of a rare autosomal allele W will be considered to be an equally weighted average of the matrilineal inclusive ¢tness (W m ) of its carriers when the allele is maternally derived and the patrilineal inclusive ¢tness (W p ) of its carriers when the allele is paternally derived, where W m and W p are calculated using coe¤-cients of matrilineal and patrilineal relatedness rather than coe¤cients of average relatedness (see Haig 1997 Haig , 2000 :
W m and W p are given equal weights because, over the course of many generations, an autosomal allele will be maternally derived half of the time and paternally derived half of the time. Our analysis will focus on the local stability of expression patterns. For this purpose, we will assume that the change in an individual's expression pattern caused by substituting a novel allele for the established allele is su¤-ciently small that we can estimate the relative ¢tness of the novel allele adequately with the ¢rst non-zero term in the series expansion:
where ¢W represents the change in ¢tness relative to the established allele and ¹ is the element of the expression vector under consideration. In these terms, a vector represents an ESP if ¢W 5 0 for all alleles in the strategy set with ¹ 0. There are two conditions under which a vector element ¹ could be evolutionarily stable. First, ¹ could occupy a local ¢tness maximum. In this case, either an increase or a decrease in expression level would result in a decrease in ¢tness. Second, ¹ could equal zero, in which case decreases in expression level are impossible and evolutionary stability simply requires that any increase in expression decreases ¢tness. These alternative criteria are summarized below:
and ¹ˆ0, @W @¹ 50.
A rare allele that di¡ers from the established allele in its madumnal expression only (¹ˆx m or y m ) is without e¡ects when paternally derived, i.e. @W p /@x mˆ@ W p /@y mˆ0 . In such cases, we only need consider e¡ects on matrilineal inclusive ¢tness, W m . Likewise, for a rare allele that di¡ers from the established allele solely in its padumnal expression (¹ˆx p or y p ), @W m /@x pˆ@ W m /@y pˆ0 and we need consider only e¡ects on patrilineal inclusive ¢tness, W p . In contrast, W m and W p must both be considered at an unimprinted locus (¹ˆx mp or y mp ).
INCLUSIVE FITNESS EFFECTS
The model assumes that the ¢tness e¡ects of an allelic substitution are limited to its impact on the personal ¢tness of the individual in which the allele is expressed and its impact on the mother's future reproduction. An individual's functional level of growth factor G is jointly determined by X and Y, where G increases monotonically with X and decreases monotonically with Y (except that G is equal to zero and invariant with respect to Y in the special case where Xˆ0). The cost of realizing a particular value of G is given by the function C( X, Y ), which represents all costs to an individual's personal ¢tness resulting from resources being committed to the synthesis, processing and secretion of the growth factor and suppressor, as well as any energy expended in the removal and degradation of the growth factor by the suppressor. C is assumed to be a monotonically increasing function of both X and Y. U, an individual's personal ¢tness before deducting C, is assumed to increase monotonically with G. We also assume that the increased demand placed on the mother by an increase in G reduces the maternal reserves available for provisioning future o¡spring. Therefore, we assume that the mother's residual reproductive value V is a decreasing function of G.
The local stability criteria in equations (6) and (7) depend on the e¡ects of changes in the gene expression levels on the inclusive ¢tness of a rare allele. The following ¢rst derivatives will be useful in our analysis:
In these equations, @V/@ G is multiplied by either p or 0.5, thereby indicating the expected fraction of the mother's future o¡spring that share a rare allele present in the current o¡spring. On average, half of these other o¡spring will share a rare madumnal allele, whereas some fraction p will share a rare padumnal allele. The value 2p can be thought of as the fraction of the mother's residual reproductive value that she shares with the father of the o¡spring possessing a rare padumnal allele (Lessells & Parker 1999) . The value of p is a function of the mating system, which is assumed to be independent of X and Y. At unimprinted loci, e¡ects on both W m and W p must be considered and the relevant ¢rst derivatives are
Our model will assume that 0 p 5 0.5, that is we assume that there is some probability that some of a mother's residual reproductive value is shared with male(s) other than the father of her current o¡spring. Subtraction of equation (8) from equation (9) gives
The term on the right-hand side of equation (14) is always positive because p 5 0.5, @V/@ G 5 0 and @G/@X 4 0. This implies
This is to say that the marginal e¡ect of an increase in X on the patrilineal inclusive ¢tness of padumnal alleles is always greater than the marginal e¡ect of the same change on the matrilineal inclusive ¢tness of madumnal alleles. The marginal e¡ect of the change on average inclusive ¢tness is of course intermediate between these values. Similarly, subtraction of equation (10) from equation (11) yields
In this case, the term on the right-hand side of equation (16) 
This is to say that the marginal e¡ect of an increase in Y on the matrilineal inclusive ¢tness of madumnal alleles is always greater than the marginal e¡ect of such a change on the patrilineal inclusive ¢tness of padumnal alleles. However, if Xˆ0, equations (10) and (16) give
i.e. decreases in Y always increase W m and W p . Therefore, natural selection will drive production of the growth suppressor to zero in the absence of the growth factor.
ESP CRITERIA (IMPRINTED LOCI)
At an ESP, all components of the pattern vector [xª m , xª p , yª m , yª p ] satisfy one of the stability criteria in equations (6) or (7). We will ¢rst consider the case in which both loci are imprinted, that is where all vector elements are free to vary independently and to take any nonnegative value. At the growth factor locus, equation (15) implies @W p /@x p 4 @W m /@x m because @W p /@x pˆ@ W p / @X and @W m /@x mˆ@ W m /@X. Therefore, the requirement that @W p /@x pˆ0 at an ESP implies @W m /@x m 5 0. In other words, if the growth factor locus is imprinted, madumnal alleles must be silent (xª mˆ0 ).
Zero padumnal production of the growth factor (xª pˆ0 ) is predicted if
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If equation (19) is satis¢ed, equation (18) implies that there will also be zero production of the growth suppressor at the ESP. If equation (19) (19) and (20) is satis¢ed, the ESP will have the form [0, xª p , yª m , 0].
CONSTRAINED ESPS (UNIMPRINTED LOCI)
We ¢rst consider the conditions for zero production at unimprinted loci. If the growth factor locus is unimprinted, zero production of the growth factor (xª mpˆ0 ) is predicted at an ESP if
It can be seen from equation (15) that equation (21) is satis¢ed if equation (19) is satis¢ed, but not vice versa. In other words, padumnal-speci¢c expression of the growth factor can be favoured under some conditions for which zero production would be favoured if the locus were unimprinted. If equation (21) is satis¢ed, equation (18) implies that there will also be zero production of the growth suppressor at the ESP regardless of whether the growth suppressor is imprinted or unimprinted. If the growth suppressor locus is unimprinted, zero production of the growth suppressor ( yª mpˆ0 ) is predicted at an ESP if
Equations (17) and (18) imply that equation (22) is satis¢ed if equation (20) is satis¢ed, but not vice versa. In other words, madumnal-speci¢c expression of the growth suppressor can be favoured under some conditions for which zero production would be favoured if the locus were unimprinted. We now consider the case where the growth factor is unimprinted but the growth suppressor is imprinted. If equation (21) is not satis¢ed, the ESP for an unimprinted growth factor will occur when @W/@x mpˆ@ W/@Xˆ0. Substituting equations (8), (9) and @W/@Xˆ0 into equation (12) gives
Since both @C/@X and @G/@X are positive, the left-hand side of equation (23) must be positive at an ESP of this type. Substituting @W m /@Yˆ0 (the stability criterion for an imprinted growth suppressor) into equation (10) gives
The left-hand side of equation (24) 
These conditions do not preclude an ESP of the form [xª mp , xª mp , yª m , 0] because @V/@ G 5 0 and p 5 0.5. We will next consider the case where neither locus is imprinted. Equation (23) is the ESP condition at the growth factor locus. At the growth suppressor locus, substituting the right-hand side of equation (23) into equation (13) gives
The quantity within the brackets and @C/@Y are always positive, whereas @G/@Y is always negative or zero. Therefore, @W/@Y must be negative and equation (22) (19) and (22) is satis¢ed, @W/@Yˆ@W p /@Xˆ0 at an ESP. Substituting these values into equations (9) and (13) gives a joint condition analogous to equation (25), i.e.
The model does not preclude an ESP of the form [0, xª p , yª mp , yª mp ] because @V/@ G 5 0 and p 5 0.5.
APPLICATION TO THE IGF2 ± IGF2R SYSTEM
The model presented above can be applied in understanding the evolution of the Igf 2^Igf 2r system. For this interpretation, X represents the expression level of the growth-enhancing factor Igf 2, Y the expression level of Igf 2r and G the steady-state level of Igf 2. As such, the model fails to capture at least one important aspect of the biology of Igf 2r. This molecule's ancestral function is as the cation-independent mannose 6-phosphate receptor (CI-MPR), which facilitates endocytosis of molecules adorned with mannose 6-phosphate residues, targeting them to lysosomes. In marsupials and eutherian mammals, CI-MPR has evolved a novel binding site for Igf 2 and has thereby acquired the additional function of degrading Igf 2. The CI-MPR does not bind Igf 2 in monotremes or birds (Killian et al. 2000) .
The model's prediction that there should be zero expression of an unimprinted growth suppressor in the absence of imprinting at the growth factor locus follows directly from the assumption that the only function of the growth suppressor is to eliminate the growth factor. However, it is clear that CI-MPR would have had nonzero expression prior to its acquisition of an Igf 2-binding site, and that production of Igf 2r/CI-MPR has ¢tness consequences that are independent of its e¡ects on Igf 2. The model can be brought into closer correspondence with reality by reinterpreting Y as being a measure of the Igf 2-degrading capacity of the CI-MPR. Thus, in the absence of the Igf 2 binding site, Yˆ0 regardless of the receptor's expression level. Once a binding site had evolved, Y became positive and increased with increases in Igf 2-binding a¤nity and with increases in the production of Igf 2r/CI-MPR. The assumption that @C/@Y 4 0 remains reasonable under this rede¢nition, even when changes in Y are due to changes in binding a¤nity rather than changes in expression level because endocytosis and degradation of Igf 2 carry metabolic costs.
Our analysis suggests a scenario for the evolution of imprinting of Igf 2 and Igf 2r (¢gure 1). At ¢rst, Igf 2 was unimprinted and the CI-MPR neither bound nor degraded Igf 2, i.e. [xª mp , xª mp , 0, 0]. This pattern of expression was destabilized by the origin of imprinting at Igf 2, which favoured silencing of madumnal Igf 2 alleles and an increase in padumnal expression to the level that optimized W p , i.e. [0, xª p , 0, 0]. Increased levels of Igf 2 created a selective force that favoured the acquisition of the Igf 2-binding site by an unimprinted Igf 2r, [0, xª p , yª mp , yª mp ]. Finally, the origin of imprinting at Igf 2r favoured silencing of padumnal alleles and an increase in madumnal expression to the level that maximized W m , i.e. [0, xª p , yª m , 0]. Thus, this scenario translates into a prediction that the evolution of imprinting at Igf 2 preceded the acquisition of an Igf 2-binding site by CI-MPR (and its transmogri¢cation into Igf 2r), which in turn preceded the evolution of imprinting at Igf 2r.
The above scenario makes three predictions about which combinations of characters will occur together when the Igf 2^Igf 2r system is studied in diverse taxa. First, madumnal silencing of Igf 2 will only occur in taxa in which enhanced growth of an o¡spring has negative ¢tness consequences for its mother's other o¡spring. Second, the Igf 2-binding site of CI-MPR will exist only in taxa in which Igf 2 is (or has been) imprinted. Third, padumnal silencing of Igf 2r will occur only in taxa in which CI-MPR binds Igf 2.
These predictions are consistent with all data currently available, but the data are as yet inadequate for eliminating alternative scenarios. Igf 2 is known to be imprinted in various muroid rodents (DeChiara et al. 1991; Pedone et al. 1994; Vrana et al. 1998) , sheep (Feil et al. 1998) , humans (Ohlsson et al. 1993 ) and the opossum Monodelphis domestica (O'Neill et al. 2000) . Imprinting of Igf 2 is believed to be restricted to mammals, although the only organism in which Igf 2 has actually been demonstrated to be unimprinted is the chicken (O'Neill et al. 2000) . Thus, all species in which Igf 2 has been shown to be imprinted have extensive post-zygotic maternal care and the data are compatible with a single origin of Igf 2 imprinting in a common ancestor of eutherian mammals and marsupials (whether Igf 2 is imprinted in monotremes is currently unknown).
CI-MPR has an Igf 2-binding site in eutherian mammals and marsupials (Dahms et al. 1993; Yandell et al. 1999; Killian et al. 2000) , but not in monotremes (Killian et al. 2000) , chickens or Xenopus (Clairmont & Czech 1989) . Thus, all taxa in which CI-MPR is known to have an IGF2-binding site are also known to imprint Igf 2, whereas no taxon is known to imprint Igf 2 but lack the binding site. These data are consistent with the prediction that Igf 2 imprinting preceded evolution of the binding site, but are also consistent with the reverse sequence.
Comparative data on Igf 2r imprinting are limited. The Igf 2r loci of mice (Barlow et al. 1991) and the opossum Didelphis virginiana are known to be imprinted (Killian et al. 2000) , whereas the Igf 2r locus of humans (Kalscheuer et al. 1993 ) and the CI-MPR locus of monotremes (Killian et al. 2000) are biallelically expressed. Thus, our historical scenario is not contradicted by any species that is known to have CI-MPR imprinting but lack the Igf 2-binding site. Transitions between orthogonally adjacent boxes arise from the introduction of a novel allele that either creates or eliminates a gene function or originates or eliminates imprinting at a locus. Transitions from the ¢rst column directly to the third or from the top to the bottom row are possible only in the case where a novel gene function evolves at a previously imprinted locus. Our proposed historical scenario for the evolution of imprinting in the Igf 2^Igf 2r system is represented by a three-step sequence beginning in the upper-middle box, moving across to the top-right corner and then down the right-hand column to the bottom right box, which represents the situation where both loci are imprinted.
The absence of Igf 2r imprinting in humans could be interpreted as evidence that the acquisition of the Igf 2-binding site preceded two independent origins of Igf 2r imprinting in mice and Didelphis, but unpublished data have suggested that Igf 2r imprinting has been lost in primates (K. Killian, personal communication) . Our model does not predict losses of imprinting, and any such loss would pose a theoretical challenge that would probably require the addition of costs of imprinting to the model.
We have predicted that imprinting of Igf 2 preceded both the evolution of the growth suppressor function and imprinting of Igf 2r. This conclusion is predicated on the assumption that CI-MPR was not already imprinted for some other reason independent of its interaction with Igf 2. Padumnal silence at a locus favours the acquisition of additional functions that reduce growth factor levels and enhance W m (whether or not the growth factor loci are imprinted), because these new functions are expressed only when an allele is maternally derived (Haig 2000 is not. Therefore, alternative scenarios would be possible if CI-MPR were padumnally silent (for some independent reason) prior to acquiring its Igf 2-binding site.
STABILITY AND METASTABILITY
The above discussion of evolutionary scenarios and alternative ESPs is based on an implicit assumption that some classes of mutations are more common than others. It would be evolutionarily meaningless to talk about ESPs' at unimprinted loci being replaced by ESPs at imprinted loci unless mutations that confer imprinting upon a previously unimprinted locus are much rarer than mutations that simply increase or decrease gene expression. Similarly, the inclusion of [0, xª p , 0, 0] as an intermediate stage in our scenario (Igf 2 imprinted and CI-MPR lacking an Igf 2-binding site) assumes that mutations that change levels of gene expression are much more common than mutations that generate a novel function for a gene product (in this case, the capacity to bind and eliminate Igf 2). Thus, [0, xª p , 0, 0] could be considered evolutionarily stable under the constraint that alleles at the second locus are unable to suppress the growth factor. Alternatively, one might call this a metastable state that is destabilized once a rare mutation (or set of mutations) that generates a growth-suppressing function occurs. Likewise, [0, xª p , yª mp , yª mp ] is metastable under the constraint that the second locus is unimprinted, but becomes unstable once a rare mutation (or set of mutations) confers imprinting upon that locus.
Whether a given state is globally stable or merely metastable with respect to a rare function-creating mutation will depend on one or more of equations (19)^(22). Within the terms of our model, any unimprinted ESP with non-zero gene expression is always destabilized by the introduction of imprinted alleles. However, such an unimprinted ESP might be globally stable if imprinting carried an inherent ¢tness cost (such as an increased risk of functional hemizygosity for deleterious alleles).
PREVIOUS MODELS
At least three previous models have considered the evolution of imprinting at growth-enhancing and growthsuppressing loci. Mochizuki et al. (1996) presented a model in which padumnal-only expression of a growth enhancer evolves when p 5 0.5. Their Appendix C extended their model to the evolution of madumnal-only expression of a growth suppressor, but only under the assumption of a ¢xed positive level of growth factor production (F m ), which was chosen to allow evolution of imprinting at the suppressor locus but was not itself required to satisfy any criterion of evolutionary stability. Spencer et al. (1998) presented a series of diallelic models in which one allele was unimprinted and the other was imprinted, but in which the levels of expression were ¢xed, given that an allele had non-zero expression. Their models were su¤ciently general to apply to either a growth-enhancing or a growth-suppressing locus, but are not comparable with the model presented in this paper because the question of evolutionary stability against the introduction of novel mutations was not addressed (see Haig 1999) . Haig & Wilkins (2000) presented a model of scramble competition within litters in which imprinting at demand-enhancing and demand-reducing loci were able to coevolve. Their model predicted padumnal-only expression of the demand enhancer and madumnal-only (or zero) expression of the demand inhibitor. The model of Haig & Wilkins (2000) di¡ered from the model presented in this paper in that it considered simultaneous rather than sequential production of o¡spring and did not consider transitions between imprinted and unimprinted states.
CONCLUSION
The model presented in this paper addresses the coevolution of genomic imprinting at two antagonistic loci, one encoding a growth factor and the other a growth suppressor, that functions through the degradation of the growth factor. We have shown that the growth factor locus, if imprinted, will be madumnally silent. Similarly, we have shown that an imprinted growth suppressor locus will be padumnally silent. Furthermore, we have presented an argument that the development of such a growth suppressor is not favoured until the growth factor locus has become imprinted. This has allowed us to hypothesize a historical scenario for the evolution of the Igf 2^Igf 2r system. We have attempted to make a number of speci¢c predictions with respect to this system that we hope will be scrutinized against comparative data from diverse taxa as they become available.
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